Arbutus biopharma corp (ABUS)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Dec'12Dec'11Dec'10
Assets
Current assets:
Cash and cash equivalents

26,416

31,799

90,082

78,872

83,969

36,942

21,933

10,193

12,461

54,292

15,225

24,212

29,851

23,413

26,630

42,970

144,772

166,779

181,089

207,205

232,276

72,187

78,177

85,267

134,357

68,717

47,024

9,030

12,412

Investments in marketable securities

-

-

0

16,410

26,621

87,675

120,085

144,676

160,079

72,060

72,954

78,797

80,528

107,146

123,052

122,340

27,802

14,525

15,006

0

-

39,974

30,580

31,966

-

-

-

-

-

Accounts receivable

1,072

1,204

2,488

1,531

923

1,431

538

1,322

719

402

846

1,042

7,878

273

395

456

340

1,008

2,192

6,332

4,564

1,903

2,094

299

1,521

117

-

-

-

Accrued revenue

-

-

-

-

-

-

0

0

128

128

128

128

128

128

128

128

128

128

454

323

1,595

538

152

200

412

212

-

-

-

Deferred expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

57

111

-

-

-

-

Investment tax credits receivable

-

-

-

-

291

-

342

342

342

340

160

160

308

293

148

148

246

246

52

55

79

86

38

40

39

40

-

-

-

Prepaid expenses and other current assets

2,370

1,790

1,771

2,770

682

3,181

1,127

1,236

1,457

2,144

1,500

1,583

1,575

1,311

1,459

2,043

1,469

1,196

1,234

1,787

1,255

1,730

696

335

561

1,084

-

-

-

Total current assets

88,333

93,828

94,341

99,583

112,486

129,229

144,025

157,769

175,186

129,366

90,813

105,922

120,268

132,564

151,812

168,085

174,757

183,882

200,027

215,702

239,769

116,418

111,737

118,164

137,001

70,343

-

-

-

Property, Plant and Equipment, Gross

-

-

-

-

-

-

16,813

16,576

25,080

24,854

24,747

24,284

22,523

17,683

14,555

14,121

13,167

12,912

12,243

12,469

11,925

12,959

13,093

13,589

13,367

13,039

-

-

-

Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment

-

-

-

-

-

-

6,392

5,895

13,251

12,671

12,125

11,541

11,061

10,738

10,469

10,177

9,925

9,729

9,918

10,433

10,147

11,199

11,480

11,913

11,846

11,666

-

-

-

Property and equipment, net of accumulated depreciation of $6,142 (December 31, 2019: $5,642)

8,176

8,676

9,150

9,402

9,667

10,145

10,421

10,681

11,829

12,183

12,622

12,743

11,462

6,945

4,086

3,944

3,242

3,183

2,325

2,036

1,778

1,760

1,613

1,676

1,521

1,373

-

-

-

Restricted investment

-

-

-

-

-

-

0

0

0

12,601

12,601

12,601

12,601

12,601

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Investment in Genevant

-

-

10,969

14,377

17,675

22,224

24,665

27,446

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investments in marketable securities, non-current

3,215

0

-

-

-

-

-

-

0

-

-

-

-

0

0

0

10,099

10,070

10,041

10,012

-

0

11,709

12,228

-

-

-

-

-

Right of use asset

2,657

2,738

2,817

2,901

3,081

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets

-

-

0

43,836

43,836

43,836

43,836

58,647

58,647

58,647

99,445

99,445

99,445

99,445

196,318

196,318

352,642

352,642

353,601

390,017

389,652

0

-

-

-

-

-

-

-

Goodwill

-

-

0

22,471

22,471

22,471

22,471

22,471

24,364

24,364

24,364

24,364

24,364

24,364

162,514

162,514

162,514

162,514

156,637

156,053

155,865

0

-

-

-

-

-

-

-

Other non-current assets

233

293

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

102,614

105,535

117,277

192,570

209,216

227,905

245,418

277,014

270,026

237,161

239,845

255,075

268,140

275,919

514,730

530,861

703,254

712,291

722,631

773,820

787,064

118,178

125,059

132,068

138,522

71,716

-

-

-

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued liabilities

3,565

7,235

8,199

7,940

6,828

9,429

8,511

7,385

6,459

10,646

6,403

8,274

7,428

9,910

7,132

7,753

7,711

8,827

7,501

6,920

14,019

9,328

5,904

3,780

4,594

3,680

-

-

-

Deferred revenue

-

-

-

-

-

-

649

974

-

2,742

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Site consolidation accrual

-

-

203

342

982

1,331

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue (note 4)

-

-

-

-

-

-

-

-

1,720

-

15

2,624

2,624

15

15

711

924

868

4,835

5,605

5,233

5,779

4,877

6,043

5,621

3,463

-

-

-

Liability-classified options

58

253

86

141

414

479

2,738

2,092

1,188

1,239

1,817

983

819

553

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Lease liability, current

408

340

329

376

599

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liability-classified options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

948

1,312

1,755

-

-

-

-

-

-

-

-

-

-

-

-

Site consolidation accrual

-

-

-

-

-

-

770

1,090

1,029

-

0

0

0

107

297

308

722

883

1,495

3,606

5,623

5,099

8,707

6,590

12,824

5,379

4,014

-

-

Total current liabilities

4,031

7,828

8,817

8,799

8,823

11,239

12,668

11,541

10,396

14,627

8,235

11,881

10,871

10,585

8,392

10,084

11,112

10,578

13,831

16,131

24,875

20,206

19,488

16,413

23,039

12,522

-

-

-

Liability related to sale of future royalties

19,375

18,992

18,675

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

-

4,130

4,783

0

0

0

0

213

6,888

8,045

7,897

9,937

10,075

10,510

10,000

-

-

-

-

Deferred rent and inducements, non-current

-

-

0

0

0

645

656

689

693

693

744

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan payable

-

-

-

-

-

-

0

0

0

12,001

12,001

12,001

12,001

12,001

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Business Combination, Contingent Consideration, Liability, Noncurrent

3,065

2,953

3,005

3,381

3,251

3,126

4,161

9,769

9,576

10,424

10,211

10,014

10,124

9,065

8,253

7,993

7,741

7,497

6,665

5,136

4,736

0

-

-

-

-

-

-

-

Lease liability, non-current

2,887

3,018

3,143

3,263

3,272

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

0

12,661

12,661

12,661

12,661

16,943

-

16,943

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

-

16,943

-

41,263

41,263

41,263

41,263

81,460

81,460

146,324

146,324

141,440

156,007

-

0

-

-

-

-

-

-

-

Deferred tax liability (note 3)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-155,865

-

-

-

-

173

-

-

-

Total liabilities

29,358

32,791

33,640

28,104

28,007

27,671

30,146

38,942

37,608

54,688

72,454

79,289

79,042

72,914

98,105

99,537

165,177

164,612

168,824

185,319

193,373

30,143

29,563

26,923

33,039

12,522

-

-

-

Stockholders’ equity:
Preferred shares, Authorized - 1,164,000 with no par value, Issued and outstanding: 1,164,000 (December 31, 2018 - 1,164,000)

140,263

137,285

134,405

131,613

128,851

126,136

123,489

120,922

118,381

49,780

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common shares, Authorized - unlimited number with no par value, Issued and outstanding: 56,850,172 (December 31, 2018 - 55,518,800)

911,099

898,535

884,623

884,623

882,143

879,405

878,805

878,191

876,288

876,108

876,049

873,841

870,847

867,393

864,375

861,148

840,475

834,240

828,578

821,660

814,441

290,004

288,355

284,790

283,640

216,702

-

-

-

Additional paid-in capital

56,803

55,246

55,385

53,738

49,594

48,084

45,500

44,429

43,769

42,840

40,755

39,758

37,809

36,543

34,486

32,817

30,243

30,206

28,538

27,844

28,590

26,208

25,872

25,655

24,837

25,343

-

-

-

Deficit

-986,932

-970,093

-942,559

-857,264

-831,187

-805,221

-784,325

-757,285

-757,835

-738,070

-699,631

-688,031

-669,776

-652,746

-432,454

-412,859

-282,859

-266,985

-261,721

-232,739

-217,853

-205,864

-199,696

-191,092

-185,011

-167,027

-

-

-

Accumulated other comprehensive loss

-47,977

-48,229

-48,217

-48,244

-48,192

-48,170

-48,197

-48,185

-48,185

-48,185

-49,782

-49,782

-49,782

-48,185

-49,782

-49,782

-49,782

-49,782

-41,588

-28,264

-31,487

-22,313

-19,035

-14,208

-17,983

-15,824

-

-

-

Stockholders' Equity Attributable to Parent

73,256

72,744

83,637

164,466

181,209

200,234

215,272

238,072

232,418

182,473

167,391

175,786

189,098

203,005

416,625

431,324

538,077

547,679

553,807

588,501

593,691

88,035

95,496

105,145

105,483

59,194

40,918

5,226

10,790

Total liabilities and stockholders’ equity

102,614

105,535

117,277

192,570

209,216

227,905

245,418

277,014

270,026

237,161

239,845

255,075

268,140

275,919

514,730

530,861

703,254

712,291

722,631

773,820

787,064

118,178

125,059

132,068

138,522

71,716

-

-

-

Marketable Securities [Member]
Investments in marketable securities, current

61,690

59,035

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-